Going Global: A Pivotal Approach for Accelerating and Scaling China’s Biopharmaceutical Industry Growth
View our Complimentary Blue Book
Frost & Sullivan have conducted extensive investigation across the global and China’s Pharmaceutical Industry and published the “2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends”, which aims to set a broad frame of the internationalization for Chinese biopharmaceutical industry as well as new industry opportunities globally.
2024 Blue Book on Chinese Biopharmaceuticals Going Global: Current Status and Trends” highlights the following:
Market Entry Analysis of Different Countries and Regions worldwide
(the United States, European Union, Japan, Southeast Asia, Brazil and Middle East)
Motivators for Chinese Biopharmaceuticals' International Expansion
(government support, technological advancements, increasing healthcare demand globally, etc.)
Analysis of the Current Status and trends of Chinese Pharmaceutical Going Global
(active pharmaceutical ingredient (APIs), Generics, Biosimilar and Innovative Drugs)
Major Strategies for Chinese innovative drugs going global
(Independent Global Expansion, Joint Global Expansion and Leveraging Partnerships for Global Expansion)
Default PDF Reader
Register to Download the Blue Book To-go
60 YEARS OF INSIGHTS
Our Global Initiatives
Empower innovation, echoing the voices of emerging technologies and companies, shaping progressive pathways in a dynamic market.
Growth Opportunity content distribution to offer a one-stop platform providing a 360-degree global perspective on the latest industry developments, events, and advancements.
Partner to equip your company with insights and enable capitalization on growth opportunities, ensuring your queries are addressed in a global marketplace.
ABOUT THE ANALYST
Charis Xu
Project Manager of Frost & Sullivan Greater China, participated in market research projects, focusing on medicine and medical device industry.
About Our Firm
Frost & Sullivan
Frost & Sullivan has partnered with clients for more than 60 years, developing growth strategies centered on innovation, disruptive technologies, emerging markets, Mega Trends, and new business models.
Copyright © 2024 Frost & Sullivan | All rights Reserved